Episode 24: Samsara Biocapital's Srini Akkaraju
BioVenture VoiCes with Chris Garabedian
00:00
China's rise and first-in-class innovation
Srini assesses China's biotech growth, where first-in-class innovation will originate, and regulatory and policy impacts.
Play episode from 01:00:00
Transcript
